Mario Tama/Getty Images News
The FDA announced on Friday that it has authorized the marketing of four Altria (New York Stock Exchange: MO) electronic cigarette products after extensive scientific review. The development was anticipated, but it also marked the first time the agency issued marketing orders granted for flavorless tobacco products. vapor products through the pre-market tobacco application route.
The FDA said it issued marketing orders to NJOY for four menthol-flavored e-cigarette products (NJOY Ace Pod Menthol 2.4%, NJOY Ace Pod Menthol 5%, NJOY Daily Menthol 4.5%, and NJOY Daily Extra Menthol 6). %). The two authorized Ace products are sealed, pre-filled, non-refillable pods for use with the previously authorized Ace device, and the two authorized Daily products are disposable e-cigarettes with a pre-filled, non-refillable e-liquid reservoir. . The FDA clearances do not apply to any other menthol-flavored e-cigarette products.
“The evidence presented by the applicant demonstrated that these menthol-flavored products provided a benefit to adult cigarette smokers compared to the tobacco-flavored products previously authorized by the applicant (in terms of complete change) that is sufficient to offset the risks of the product, including youth appeal.”
During the company's latest earnings call (transcript), CEO Billy Gifford said Altria (MO) saw continued early momentum from NJOY and expects to expand the brand to 100,000 stores by the end of the year.
Altria Group (MO) shares rose 0.18% higher on Friday.
